GLP-1 receptor agonists and GLP-1/GIP combination therapies have become foundational treatments for type 2 diabetes and obesity
This can help customers coordinate device and packaging sourcing
Likewise, increasing dietary fiber can enhance bowel function and decrease the risk of inflammatory conditions in the digestive tract
Bu LL, Liu YQ, Shen Y, Fan Y, Yu WB, Jiang DL, et al
Notably, the current evidence base for GLP-1 RAs in MC4R -deficient obesity spans a wide age range, from children as young as 9 years to adults, yet pediatric-specific considerations remain inadequately addressed
Alcohol use disorder identification test (AUDIT) AUDIT is a 10-item Core questionnaire to identify hazardous drinkers (whose drinking increases their risk of alcohol-related problems, though alcohol-associated harm has not yet occurred)